Previous 10 | Next 10 |
ORLANDO, FL / ACCESSWIRE / October 4, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) with Kindeva Drug Delivery have demonstrated enhanced abuse deterrence kinetics of the Company's patented lead product, Aversa™ Fentanyl, an abuse-deterrent fentanyl transdermal system, with their ...
ORLANDO, FL / ACCESSWIRE / October 3, 2022 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") today announced that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Hori...
Nutriband press release ( NASDAQ: NTRB ): Q2 GAAP EPS of -$0.12. Revenue of $0.5M (+150.0% Y/Y). For further details see: Nutriband GAAP EPS of -$0.12, revenue of $0.5M
ORLANDO, FL / ACCESSWIRE / September 8, 2022 / Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, today announced financial and operational results for the second quarter ended July 31, 2022. Key Highlights: Generated record quarterly revenue of $0.5 milli...
ORLANDO, FL / ACCESSWIRE / August 16, 2022 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") announced today that the 7:6 forward split of its common stock was effective at the opening of trading on Friday, August 12, 2022, with a record date of Monday, August 15, ...
ORLANDO, FL / ACCESSWIRE / August 10, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) ("Nutriband" or the "Company") announced on July 27, 2022 that its Board of Directors had approved and declared a 7:6 forward split of its common stock with a record date of Monday, August 15, 2022 (the "...
ORLANDO, FL / ACCESSWIRE / August 1, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that it has received a Notice of Allowance from the Canadian Intellectual Property Office (CIPO) for its patent application, CA 2937649, entitled "Abuse and Misuse Deterrent Transdermal Sys...
Gainers: Ayala Pharmaceuticals ( AYLA ) +27% . GeoVax Labs ( GOVX ) +20% . Senti Biosciences ( SNTI ) +17% . Omeros ( OMER ) +15% . CVRx ( CVRX ) +9% . Losers: Nutriband ( NTRB ) -15% . Bausch Health Companies ...
Gainers: Blue Water Vaccines ( BWV ) +69% . Leafly Holdings ( LFLY ) +25% . AlloVir ( ALVR ) +23% . Teva Pharmaceutical ( TEVA ) +21% . Nutriband ( NTRB ) +17% . Losers: ObsEva ( OBSV ) -68% . Cassava Scie...
Nutriband ( NASDAQ: NTRB ) board approved and declared a 7:6 forward split of its common stock that is expected to be effective Aug.15, 2022 after market opens. Post stock split, holders of pre-split shares of common stock have the right to receive post-split shares o...
News, Short Squeeze, Breakout and More Instantly...
Nutriband (NASDAQ: NTRB) , a pharmaceutical company with a special focus on transdermal technologies, is inviting investors to a live webinar. Scheduled for July 25, 2024, at 4:15 p.m. ET, this exclusive event will be hosted by RedChip Companies. During the webinar, Nutriband Chairman and Preside...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on July 25, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Nutriband Cha...
Nutriband (NASDAQ: NTRB) , a developer of transdermal pharmaceutical products, has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”). According to the announcement, the notice means that the USPTO anticipates granting the trademark registrat...